Literature DB >> 7598372

Facial nerve paralysis induced by herpes simplex virus in mice: an animal model of acute and transient facial paralysis.

T Sugita1, S Murakami, N Yanagihara, Y Fujiwara, Y Hirata, T Kurata.   

Abstract

We have been the first to succeed in producing an acute and transient facial paralysis simulating Bell's palsy, by inoculating herpes simplex virus into the auricles or tongues of mice. The KOS strain of the virus was injected into the auricle of 104 mice and the anterior two thirds of the tongue in 30 mice. Facial paralysis developed between 6 and 9 days after virus inoculation, continued for 3 to 7 days, and then recovered spontaneously. The animals were painlessly sacrificed between 6 and 20 days after inoculation for histopathologic and immunocytochemical study. Histopathologically, severe nerve swelling, inflammatory cell infiltration, and vacuolar degeneration were manifested in the affected facial nerve and nuclei. Herpes simplex virus antigens were also detected in the facial nerve, geniculate ganglion, and facial nerve nucleus. The pathophysiologic mechanisms of the facial paralysis are discussed in light of the histopathologic findings, in association with the causation of Bell's palsy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7598372     DOI: 10.1177/000348949510400713

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  18 in total

1.  Delayed facial nerve decompression for Bell's palsy.

Authors:  Sang Hoon Kim; Junyang Jung; Jong Ha Lee; Jae Yong Byun; Moon Suh Park; Seung Geun Yeo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-08-30       Impact factor: 2.503

2.  Comparison of hearing results following the use of NiTiBOND versus Nitinol prostheses in stapes surgery: a retrospective controlled study reporting short-term postoperative results.

Authors:  Péter Révész; István Szanyi; Gábor Ráth; Tímea Bocskai; László Lujber; Zalán Piski; Tamás Karosi; Imre Gerlinger
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-28       Impact factor: 2.503

3.  The facial nerve canal in patients with Bell's palsy: an investigation by high-resolution computed tomography with multiplanar reconstruction.

Authors:  Aya Murai; Shin Kariya; Kouzou Tamura; Akira Doi; Kenichi Kozakura; Mitsuhiro Okano; Kazunori Nishizaki
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-11       Impact factor: 2.503

Review 4.  Etiology and therapy of delayed facial paralysis after middle ear surgery.

Authors:  Jonas Eckermann; Jens Eduard Meyer; Thomas Guenzel
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-01       Impact factor: 2.503

5.  Steroid-antivirals treatment versus steroids alone for the treatment of Bell's palsy: a meta-analysis.

Authors:  Yabing Dong; Yong Zhu; Chuan Ma; Huaqiang Zhao
Journal:  Int J Clin Exp Med       Date:  2015-01-15

6.  A cell culture model of facial palsy resulting from reactivation of latent herpes simplex type 1.

Authors:  Maggie A Kuhn; Shruti Nayak; Vladimir Camarena; Jimmy Gardner; Angus Wilson; Ian Mohr; Moses V Chao; Pamela C Roehm
Journal:  Otol Neurotol       Date:  2012-01       Impact factor: 2.311

7.  Involvement of MAPK ERK activation in upregulation of water channel protein aquaporin 1 in a mouse model of Bell's palsy.

Authors:  Fan Fang; Cai-Yue Liu; Jie Zhang; Lie Zhu; Yu-Xin Qian; Jing Yi; Zheng-Hua Xiang; Hui Wang; Hua Jiang
Journal:  J Mol Neurosci       Date:  2014-12-20       Impact factor: 3.444

8.  The expression of IL-2 and IL-4 in CD4(+) T cells from mouse lymph nodes and spleen during HSV-1-induced facial palsy.

Authors:  Lintao Gu; Yuechen Han; Wenwen Liu; Yanyan Mao; Jianfeng Li; Haibo Wang
Journal:  Inflamm Res       Date:  2013-11-27       Impact factor: 4.575

9.  Frequent detection of Mycoplasma pneumoniae in Bell's palsy.

Authors:  C Völter; J Helms; B Weissbrich; P Rieckmann; M Abele-Horn
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-24       Impact factor: 2.503

10.  Quantitative analysis of herpes simplex virus in cranial nerve ganglia.

Authors:  Jeffrey T Vrabec; Raye L Alford
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.